CVS Health(US:CVS)2025-10-29 12:00Financial Performance & Guidance - CVS Health delivered consolidated revenue growth of 7.8% in the third quarter of 2025 [6] - Adjusted EPS for the third quarter of 2025 was $1.60 [6, 7] - The company raised its 2025 adjusted EPS guidance to a range of $6.55 to $6.65 [6, 19] - CVS Health anticipates at least $397.3 billion in consolidated revenue for full year 2025 [8] - Full year 2025 cash flow from operations is projected to be between $7.5 billion and $8.0 billion [8] Segment Performance - Health Care Benefits total revenues for 3Q 2025 were $36.0 billion [24] - Health Services total revenues for 3Q 2025 were $49.3 billion [27] - Pharmacy & Consumer Wellness total revenues for 3Q 2025 were $36.2 billion [31] - Same store pharmacy sales increased by approximately 16.8% and same store prescription volumes increased by approximately 8.9% [32] - Retail pharmacy script share reached approximately 28.9% [32]